<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35987973</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2240-2993</ISSN><JournalIssue CitedMedium="Internet"><Volume>123</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Acta neurologica Belgica</Title><ISOAbbreviation>Acta Neurol Belg</ISOAbbreviation></Journal><ArticleTitle>Investigation of non-motor symptoms in patients with amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>1797</StartPage><EndPage>1804</EndPage><MedlinePgn>1797-1804</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13760-022-02036-6</ELocationID><Abstract><AbstractText>[Objective] Few studies have comprehensively investigated the non-motor symptoms of amyotrophic lateral sclerosis (ALS). We aimed to investigate this aspect of ALS. [Methods] We held a nationwide webinar, titled "ALS Caf&#xe9;," and distributed self-report questionnaires to ALS patients. In addition to the frequency of non-motor symptoms such as fatigue, pain, sleep disorders, defecation disorders, sialorrhea, and sexual problems, we evaluated the quality of life (QoL), ALS Functional Rating Scale-Revised (ALSFRS-R), and Patient Health Questionnaire-9 (PHQ-9). [Results] The average age of the 33 respondents (19 male, 14 female) was 60.8&#x2009;&#xb1;&#x2009;11.2; 96.7% of respondents had some non-motor symptoms. The median ALSFRS-R was 32.0, and seven (21.2%) of the respondents had a PHQ-9 score of 10 or higher. Fatigue was the most common non-motor symptom (81.8%), followed by pain (60.6%), defecation disorders (57.6%), sleep disorders (48.5%), sialorrhea (48.5%), and sexual problems (24.2%). Fatigue was more frequent in females (P&#x2009;=&#x2009;0.03). Among the non-motor symptoms, pain was the most common factor affecting QoL, followed by fatigue. More than 90% of ALS patients answered that they had never consulted a physician/counselor about sexual problems. Patients with pain had higher PHQ-9 scores than those without (P&#x2009;=&#x2009;0.01). There was no correlation between the ALSFRS-R score and QoL and PHQ-9. [Conclusions] Most patients with amyotrophic lateral sclerosis had non-motor symptoms, and fatigue and pain were the most common. We showed that many non-motor symptoms affected QoL without correlating with ALSFRS-R score. Attention should be paid to those even if the motor symptoms of ALS are mild.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hirayama</LastName><ForeName>Takehisa</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3056-3176</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Faculty of Medicine, Toho University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shibukawa</LastName><ForeName>Mari</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Faculty of Medicine, Toho University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yanagihashi</LastName><ForeName>Masaru</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Faculty of Medicine, Toho University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warita</LastName><ForeName>Hitoshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tohoku University Hospital, Sendai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atsuta</LastName><ForeName>Naoki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Aichi Medical University School of Medicine, Nagakute, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamanaka</LastName><ForeName>Koji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kano</LastName><ForeName>Osamu</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Neurology, Faculty of Medicine, Toho University, Tokyo, Japan. osamu.kano@med.toho-u.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>22wm0425014h0001</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Acta Neurol Belg</MedlineTA><NlmUniqueID>0247035</NlmUniqueID><ISSNLinking>0300-9009</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012798" MajorTopicYN="Y">Sialorrhea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012893" MajorTopicYN="Y">Sleep Wake Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Fatigue</Keyword><Keyword MajorTopicYN="N">Non-motor symptoms</Keyword><Keyword MajorTopicYN="N">Pain</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword></KeywordList><CoiStatement>All the authors report no conflict of interest relevant to the manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>18</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>20</Day><Hour>23</Hour><Minute>58</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35987973</ArticleId><ArticleId IdType="pmc">PMC10505101</ArticleId><ArticleId IdType="doi">10.1007/s13760-022-02036-6</ArticleId><ArticleId IdType="pii">10.1007/s13760-022-02036-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mitsumoto H, Chad DA, Pioro EP (1998) Amyotrophic lateral sclerosis. F. A. Davis Company, Philadelphia.</Citation></Reference><Reference><Citation>Fang T, Jozsa F, Al-Chalabi A. Nonmotor symptoms in amyotrophic lateral sclerosis: a systematic review. Int Rev Neurobiol. 2017;134:1409&#x2013;1441. doi: 10.1016/bs.irn.2017.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.irn.2017.04.009</ArticleId><ArticleId IdType="pubmed">28805578</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;nther R, Richter N, Sauerbier A, et al. Non-motor symptoms in patients suffering from motor neuron diseases. Front Neurol. 2016;7:117. doi: 10.3389/fneur.2016.00117.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2016.00117</ArticleId><ArticleId IdType="pmc">PMC4958907</ArticleId><ArticleId IdType="pubmed">27504105</ArticleId></ArticleIdList></Reference><Reference><Citation>Prell T, Gaur N, Stubendorff B, et al. Disease progression impacts health-related quality of life in amyotrophic lateral sclerosis. J Neurol Sci. 2019;397:92&#x2013;95. doi: 10.1016/j.jns.2018.12.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2018.12.035</ArticleId><ArticleId IdType="pubmed">30597420</ArticleId></ArticleIdList></Reference><Reference><Citation>Beswick E, Forbes D, Hassan Z, et al. A systematic review of non-motor symptom evaluation in clinical trials for amyotrophic lateral sclerosis. J Neurol. 2022;269:411&#x2013;426. doi: 10.1007/s00415-021-10651-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10651-1</ArticleId><ArticleId IdType="pmc">PMC8738361</ArticleId><ArticleId IdType="pubmed">34120226</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606&#x2013;613. doi: 10.1046/j.1525-1497.2001.016009606.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1525-1497.2001.016009606.x</ArticleId><ArticleId IdType="pmc">PMC1495268</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId></ArticleIdList></Reference><Reference><Citation>Levis B, Benedetti A, Thombs BD, DEPRESsion Screening Data (DEPRESSD) Collaboration Accuracy of patient health questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis. BMJ. 2019;365:l1476. doi: 10.1136/bmj.l1476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l1476</ArticleId><ArticleId IdType="pmc">PMC6454318</ArticleId><ArticleId IdType="pubmed">30967483</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry JD, Paganoni S, Carlson K, et al. Design and results of a smartphone-based digital phenotyping study to quantify ALS progression. Ann Clin Transl Neurol. 2019;6:873&#x2013;881. doi: 10.1002/acn3.770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.770</ArticleId><ArticleId IdType="pmc">PMC6529832</ArticleId><ArticleId IdType="pubmed">31139685</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanda Y. Investigation of the freely available easy-to-use software &#x201c;EZR&#x201d; for medical statistics. Bone Marrow Transplant. 2013;48:452&#x2013;458. doi: 10.1038/bmt.2012.244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bmt.2012.244</ArticleId><ArticleId IdType="pmc">PMC3590441</ArticleId><ArticleId IdType="pubmed">23208313</ArticleId></ArticleIdList></Reference><Reference><Citation>McElhiney MC, Rabkin JG, Gordon PH, et al. Prevalence of fatigue and depression in ALS patients and change over time. J Neurol Neurosurg Psychiatry. 2009;80:1146&#x2013;1149. doi: 10.1136/jnnp.2008.163246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2008.163246</ArticleId><ArticleId IdType="pubmed">19762902</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez C, Piemonte ME, Callegaro D, Da Silva HC. Fatigue in amyotrophic lateral sclerosis: frequency and associated factors. Amyotroph Lateral Scler. 2008;9:75&#x2013;80. doi: 10.1080/17482960701642502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960701642502</ArticleId><ArticleId IdType="pubmed">17924237</ArticleId></ArticleIdList></Reference><Reference><Citation>Wigand B, Schlichte I, Schreiber S, et al. Characteristics of pain and the burden it causes in patients with amyotrophic lateral sclerosis&#x2014;a longitudinal study. Amyotroph Lateral Scler Frontotemporal Degener. 2021;14:1&#x2013;8. doi: 10.1080/21678421.2021.1962354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2021.1962354</ArticleId><ArticleId IdType="pubmed">34392762</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran C, Bril V, Katzberg HD, Barnett C. Fatigue is a relevant outcome in patients with myasthenia gravis. Muscle Nerve. 2018;58:197&#x2013;203. doi: 10.1002/mus.26069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26069</ArticleId><ArticleId IdType="pubmed">29342314</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferentinos P, Kontaxakis VP, Havaki-Kontaxaki BJ, et al. Fatigue in female patients with major depression: the effect of comorbid anxiety disorders. Psychiatriki. 2011;22:320&#x2013;329.</Citation><ArticleIdList><ArticleId IdType="pubmed">22271845</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Mora G, Lauria G. Pain in amyotrophic lateral sclerosis. Lancet Neurol. 2017;16:144&#x2013;157. doi: 10.1016/S1474-4422(16)30358-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(16)30358-1</ArticleId><ArticleId IdType="pubmed">27964824</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucia D, McCombe PA, Henderson RD, Ngo ST. Disorders of sleep and wakefulness in amyotrophic lateral sclerosis (ALS): a systematic review. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22:161&#x2013;169. doi: 10.1080/21678421.2020.1844755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1844755</ArticleId><ArticleId IdType="pubmed">33191797</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Coco D, Puligheddu M, Mattaliano P, et al. REM sleep behavior disorder and periodic leg movements during sleep in ALS. Acta Neurol Scand. 2017;135:219&#x2013;224. doi: 10.1111/ane.12593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.12593</ArticleId><ArticleId IdType="pubmed">27027974</ArticleId></ArticleIdList></Reference><Reference><Citation>Parra-Cantu C, Zaldivar-Ruenes A, Martinez-Vazquez M, Martinez HR. Prevalence of gastrointestinal symptoms, severity of dysphagia, and their correlation with severity of amyotrophic lateral sclerosis in a Mexican cohort. Neurodegener Dis. 2021;21:42&#x2013;47. doi: 10.1159/000517613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000517613</ArticleId><ArticleId IdType="pubmed">34139704</ArticleId></ArticleIdList></Reference><Reference><Citation>Toepfer CF, Klauser A, Riepl RL, et al. Gastrointestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Mot Neuron Disord. 1999;1:15&#x2013;19. doi: 10.1080/146608299300079484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608299300079484</ArticleId><ArticleId IdType="pubmed">12365061</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltadzhieva R, Gurevich T, Korczyn AD. Autonomic impairment in amyotrophic lateral sclerosis. Curr Opin Neurol. 2005;18:487&#x2013;493. doi: 10.1097/01.wco.0000183114.76056.0e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.wco.0000183114.76056.0e</ArticleId><ArticleId IdType="pubmed">16155429</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Yang X, Han Q, et al. Prevalence of sialorrhea among amyotrophic lateral sclerosis patients: a systematic review and meta-analysis. J Pain Symptom Manage. 2021 doi: 10.1016/j.jpainsymman.2021.12.005,34920148.Review.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpainsymman.2021.12.005,34920148.Review</ArticleId><ArticleId IdType="pubmed">34920148</ArticleId></ArticleIdList></Reference><Reference><Citation>Banfi P, Ticozzi N, Lax A, et al. A Review of options for treating sialorrhea in amyotrophic lateral sclerosis. Respir Care. 2015;60:446&#x2013;454. doi: 10.4187/respcare.02856.</Citation><ArticleIdList><ArticleId IdType="doi">10.4187/respcare.02856</ArticleId><ArticleId IdType="pubmed">25228780</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahbazi M, Holzberg S, Thirunavukkarasu S, Ciani G. Perceptions of sexuality in individuals with amyotrophic lateral sclerosis (ALS) and their treating clinicians. NeuroRehabilitation. 2017;41:331&#x2013;342. doi: 10.3233/NRE-172204.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/NRE-172204</ArticleId><ArticleId IdType="pubmed">29036846</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti B, Carelli L, Solca F, et al. Sexuality and intimacy in ALS: systematic literature review and future perspectives. J Neurol Neurosurg Psychiatry. 2019;90:712&#x2013;719. doi: 10.1136/jnnp-2018-319684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319684</ArticleId><ArticleId IdType="pubmed">30538137</ArticleId></ArticleIdList></Reference><Reference><Citation>Grehl T, Rupp M, Budde P, et al. Depression and QOL in patients with ALS: how do self-ratings and ratings by relatives differ? Qual Life Res. 2011;20:569&#x2013;574. doi: 10.1007/s11136-010-9781-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-010-9781-7</ArticleId><ArticleId IdType="pubmed">21086185</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabkin JG, Goetz R, Factor-Litvak P, et al. Depression and wish to die in a multicenter cohort of ALS patients. Amyotroph Later Scler Frontotemporal Degener. 2015;16:265&#x2013;273. doi: 10.3109/21678421.2014.980428.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.980428</ArticleId><ArticleId IdType="pmc">PMC4441849</ArticleId><ArticleId IdType="pubmed">25482273</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>